← Evidence map

ArticleTheranostics2025

A bifunctional fusion membrane-based biocompatible nanovaccine to potentiate cancer immunotherapy.

Wei Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40365290